Contribution of RGA preserving PPPD for reducing complication rate of duodenojejunostomy compared to RGA transecting PPPD: A randomized controlled trial

Contribution of RGA preserving PPPD for reducing complication rate of duodenojejunostomy compared to RGA transecting PPPD: A randomized controlled trial - Contribution of RGA preserving PPPD for reducing complication rate of duodenojejunostomy compared to RGA transecting PPPD: A randomized controlled trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000061062

Enrollment

140

Registered

2026-04-01

Start date

2026-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with HPB/duodenal diseases requiring PPPD

Interventions

Preservation of RGA Transection of RGA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 Patients requiring PPPD due to HPB/duodenal diseases 2 Age over 18 years old 3 Obtaining written informed consent

Exclusion criteria

Exclusion criteria: 1 Prior chemotherapy and/or radiotherapy, conversion case 2 Bulky LN metastasis at baseline 3 Requiring vessel reconstruction 4 Any patinets judged as insuitable for enrollment

Design outcomes

Primary

Measure	Time frame
To clarify the significance of RGA preserving PPPD for reducing complication rate of duodenojejunostomy	—

Countries

Japan

Contacts

Public ContactAkira Umemura

School of Medicine, Iwate Medical University Department of Surgery

aumemura@iwate-med.ac.jp0196137111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026